Good Neighbor Pharmacy joins more than 150 pharmacy stakeholders signing a letter to Secretary Azar, urging him to address pharmacy DIR fees in the administrations drug pricing blueprint.
The group of 153 multi-disciplined stakeholders who represent pharmacies and pharmacists and have a vested interest in lowering drug prices and seniors’ out-of-pockets costs signed in support of the letter, urging the administration to move forward with a proposal to address pharmacy direct and indirect remuneration (DIR) fees in the Medicare Part D program.
Thank you to the National Community Pharmacists Association (NCPA) for coordinating submission of the letter to Secretary Azar.
A final copy of the letter that was submitted listing all signatories is available here
FROM NCPA: Urge Legislators to Voice Support for Addressing Pharmacy DIR in Drug Pricing Blueprint
Visit NCPA’s Legislative Action Center
to contact your Senators and Representative and urge them to sign onto a bipartisan letters to HHS Secretary Alex Azar being led by Senators Shelley Moore Capito (R-W.Va.) and Jon Tester (D-Mont.)in the Senate and Representatives Morgan Griffith (R-Va.) and Peter Welch (D-Vt.) in the House. The letters urge Secretary Azar to address retroactive pharmacy direct and indirect remuneration fees (DIR) in Medicare Part D as part of any attempts to lower drug prices.